Diego Miralles

Dr. Diego Miralles, MD, is a President & Head-Research & Development at Artiva Biotherapeutics, Inc., an Adjunct Professor at University of California San Diego and a Venture Partner at CHP Management, Inc. He is on the Board of Directors at Contineum Therapeutics, Inc., S.V.D.P.
Management, Inc., Artiva Biotherapeutics, Inc., Rady Children's Institute for Genomic Medicine and ArrePath, Inc. Dr. Miralles was previously employed as an Advisor by Flagship Pioneering, Inc., a President, Chief Executive Officer & Director by Laronde, Inc., a Chief Executive Officer & Director by Vividion Therapeutics, Inc., a President by Adaptive Therapeutics, Inc., a Senior Director by Trimeris, Inc., a Medical Director by Triangle Pharmaceuticals, Inc., an Assistant Professor by Duke University Medical Center, and a Member-Management Board by Tibotec Virco Virology BV.
He also served on the board at Neubase Therapeutics, Inc. /Old/, NeuBase Therapeutics, Inc. and CONNECT.
He received his doctorate degree from Universidad de Buenos Aires.